Half-year report
Molten Ventures VCT
plcLEI:
2138003I9Q1QPDSQ9Z97Half-Year
Report14 December 2023
Recent performance summary
|
30 Sept 2023 |
31 Mar2023 |
30 Sept 2022 |
|
Pence |
Pence |
Pence |
Net Asset Value (“NAV”) per Share |
49.9 |
53.3 |
52.8 |
Cumulative distributions paid per Share |
115.1 |
113.6 |
113.6 |
Total Return per Share |
165.0 |
166.9 |
166.4 |
|
|
|
|
CHAIRMAN’S STATEMENTI am
pleased to present the Half-Yearly Report for the Company for the
six months ended 30 September 2023.
Market conditions have remained difficult
throughout the period, however we have seen a steady level of new
investment activity, utilising some of the funds raised from the
successful offer for subscription earlier this year.
Net Asset Value and resultsAt
30 September 2023, the Company’s Net Asset Value per share (“NAV”)
stood at 49.9p, a decrease of 1.9p or 3.6% since 31 March 2023
(after adding back the dividend paid during the period).
The loss on ordinary activities after taxation
for the period was £3.8 million, comprising a revenue loss of
£209,000 and a capital loss of £3.6 million.
DividendIn 2023, the Company
paid dividends in April and September 2023, totalling 1.5p. As
explained in the 2023 Annual Report, VCT regulations restrict the
payment of dividends out of reserves related to funds raised in the
last three to four years. Following a series of successful
fundraising offers in recent years, the Company has raised
substantial levels of funds and as a result the Board currently has
to carefully monitor reserves to ensure that the VCT regulations
remain adhered to. The Board targets a total annual dividend of
equal to 5% of net asset value, although ensuring continuing
compliance with the VCT regulations will always take precedent.
As a result of the above, the Board is not
proposing to pay a dividend prior to the end of the accounting
period but intends to review this and continue a strong dividend
policy once a greater level of reserves is “unlocked” from the VCT
regulation restrictions in future.With this in mind, the Company
will pay an interim dividend on 5 April 2024 of 1.0p per
share, to Shareholders on the register at 23 February 2024.
Shareholders are reminded that the Company
operates a Dividend Reinvestment Scheme, which allows Shareholders
to automatically reinvest their dividends into new shares in the
Company and obtain further income tax relief on that investment.
Further details about how to opt-in can be found in the
“Shareholder Information” section on the inside cover of this
report. The last date for elections under the Dividend Reinvestment
Scheme for the above dividend will be 8 March 2024.
Venture capital
investmentsDuring the period, the Company made four new
and three follow-on investments, at a total cost of £13.2
million.
New investments were made in Morressier GmbH,
Melio Healthcare Limited, Binalyze OU, and Oliva Health Holdings
Inc. Follow-on investments were made in Global Satellite Vu
Limited, Allplants Limited, and Apperio Limited.
At the period end, the Company held a portfolio
of 52 venture capital investments, valued at £92.2 million.
As usual, the Board has reviewed the valuations
of the unquoted investments as at 30 September 2023 and a number of
adjustments to their carrying values have been made. This has
resulted in a net valuation downturn of £2.6 million for the period
across the whole portfolio.
The Company holds two AIM-quoted investments;
Access Intelligence plc and Fulcrum Utility Services Limited, which
are both valued at their share prices as at 30 September 2023. The
valuation of the investment in Access Intelligence saw a decrease
of £1.7 million over the period and that in Fulcrum of
£383,000.
Fundraising As noted in the
last Annual Report, the Company closed a successful offer for
subscription in February 2023, having raised
£29.6 million.
In view of the strong demand from investors and
the expectation of a continuing stream of good quality deal flow,
the Company launched a new offer for subscription in October,
seeking to raise up to £20 million (with an overallotment facility
of £20 million to be used at the Directors’ discretion).
Approximately £3.5 million has been raised to date.
Shareholders can find full details of the offer,
including the prospectus, and online application
at:investors.moltenventures.com/investor-relations/vct
Investors are recommended to consult their
financial adviser before making any investment decisions.
Share buybacksThe Company
continues to operate a policy of buying in its shares that become
available in the market at approximately a 5% discount to the
latest published NAV, subject to regulatory and liquidity
constraints.
In line with this policy, during the period, the
Company purchased 1,233,000 shares for cancellation at an average
price of 48.91p per share.
As noted above in respect of the dividend, the
Board is currently monitoring the Company’s reserves to ensure
continued compliance with the VCT regulations. In view of this, it
is not expected that any further share buybacks will be made prior
to the end of March 2024. However, the Board confidently expects to
resume buybacks, subject to the above, in the Company’s next
financial year.
Any Shareholders considering selling their
shares will need to use a stockbroker, whom you should ask to
contact Panmure Gordon (UK) Limited, who acts as the Company’s
corporate broker, and maintains a list of potential sellers to be
contacted when the next buyback is undertaken by the Company.
OutlookAlthough we have seen a
slight fall in NAV over the period, the Board is satisfied with the
approach taken by the manager in supporting existing portfolio
companies and continuing to identify suitable new
opportunities.
We are hopeful that conditions will begin to
improve in 2024 and that we may now be approaching a point in the
cycle when excellent investment opportunities in the sectors in
which your Company operates are available at attractive prices
which can drive strong performance in future.
I look forward to updating Shareholders on
progress in my statement in the Annual Report to 31 March 2024,
which will be published in the summer.
David BrockChairman
INVESTMENT MANAGER’S REPORT
The challenging market backdrop has continued
for the period however we continue to actively support our
portfolio companies as well as making new investments.
The valuation movements in the first half of the
year showed a NAV Total Return (NAVTR - adding back dividends paid
in the period) decrease of 3.6%. While we are disappointed to
report this small decline in NAVTR in the period, our long-held and
consistent approach to valuations has enabled the manager to
demonstrate relative resilience. Having acted quickly at the onset
of the downturn in early 2022, we are now seeing evidence of
greater stability in our valuations, and we anticipate further
stabilisation, and in parts, recovery.
Following a successful fundraising season,
deployment has been strong for the first seven months of the year.
Including one new investment made post the period end, the team
completed eight investments totalling £15.9 million. This compares
with a total invested in the previous twelve months of £17.3
million. This comprised five new investments totalling £12.1
million alongside three follow-on investments totalling £3.8
million.
At the period end, Molten technology companies
represented 87% of the portfolio and legacy companies 13%. The net
asset valuation split was 76% in investments, and 24% in cash and
other net current assets, which was reduced by the new investment
made post the period end.
Five new investments (including one made post
the period end), alongside the Molten EIS and Molten Ventures plc
funds, were made into the following companies:
|
£’000 |
Oliva Health
Holdings IncNon-clinical mental health solutions |
1,628 |
Morressier
GmbHPublishes workflow and integrity software |
3,162 |
Binalyze
OUCybersecurity Forensics and incident response |
2,161 |
Melio Healthcare
Limited t/a IMU BioscienceImmune system bio diagnostics |
2,520 |
Anima Group Inc
(made after the period end)Care enablement platform |
2,653 |
|
12,124 |
In the period, one portfolio company, Global
Satellite Vu Limited, attracted a £12.7 million follow-on
investment bringing their total investment to £30.5m in venture
capital funding. The round was led by Molten Ventures, with
participation from Seraphim Space Investment Trust PLC, A/O
Proptech, Lockheed Martin, Ridgeline Ventures, Earth Sciences
Foundation, and Stellar Ventures - all existing investors.
Global Satellite Vu Limited, is a UK-based
company that is launching a constellation of infrared satellites
capable of monitoring the thermal footprint of any building on
earth multiple times a day. The technology, built by Airbus, is
proven, and there's commercial exclusivity over the intellectual
property in perpetuity. The first satellite launched in June 2023
with SpaceX. By 2024/5 a constellation of just 7 satellites will
provide global coverage with the ability to capture data over
specific areas of interest 10-20 times a day.
Global Satellite Vu is not just focusing on
delivering geospatial intelligence for defence and government
customers; its long-term vision is to create proprietary data,
analytics, and solutions focusing on energy efficiency, retrofit,
and net-zero markets. Global Satellite Vu has already secured
customer commitments through its Early Access Option Programme
(EAP) valued at over £128 million.
Two further smaller follow-on investments were
made into Apperio Limited and AllPlants Limited.
There were no successful exits in the period,
however, post the period end Fluidic Analytics entered
administration. While disappointing from a returns perspective, we
are hopeful that the technology will be sold to continue the
ground-breaking work achieved by the company.
Following the successful fundraise of £29.6
million in the last tax season, the Company recently launched its
new fundraising offer with a target first close of £20 million. The
prospectus is available to download from the VCT’s website at
investors.moltenventures.com/investor-relations/vctAccess to the
application portal and other documentation is also available on
that page.
The Investment Manager is an active member of
the VCT Association (VCTA) which represents 13 of the largest VCT
fund managers and makes up over 90% of the £6.6 billion VCT
industry. We were delighted to see that the Chancellor has
officially confirmed the extension of the sunset clause on the VCT
scheme to 2035. This fantastic result is a testament to the hard
work of the VCTA and its members over the last few years. The data,
resources and site visit opportunities provided by VCT managers
were vital in helping to make the case to HM Treasury that the VCT
scheme deserves to be extended and help the next generation of
British businesses scale and grow.
As your fund manager, we are cautiously
optimistic for the year ahead as the technology markets continue to
stabilise and recover in places. Our focus remains on positioning
ourselves to capture exceptional opportunities at attractive
valuations in what is increasingly a buyers’ market for venture
capital.
Elderstreet Investments
LimitedPart of the Molten Ventures
Group
SUMMARY OF INVESTMENT
PORTFOLIO
Investment Portfolio as at 30 September 2023 |
Cost |
Valuation |
Valuationmovementin
period |
% of portfolioby
value |
|
£’000 |
£’000 |
£’000 |
|
Top
ten venture capital investments |
|
|
|
|
Thought
Machine Group Limited |
2,400 |
9,688 |
(613) |
8.0% |
Endomagnetics
Limited |
2,147 |
8,698 |
63 |
7.2% |
Form3
Limited |
1,420 |
8,251 |
1,646 |
6.8% |
Fords
Packaging Topco Limited |
2,433 |
5,867 |
- |
4.8% |
Focal Point
Positioning Limited |
3,300 |
5,561 |
- |
4.6% |
Global
Satellite Vu Limited |
4,089 |
4,688 |
583 |
3.9% |
Access
Intelligence plc* |
2,586 |
4,488 |
(1,741) |
3.7% |
River Lane
Research Limited |
2,661 |
4,113 |
- |
3.4% |
IESO Digital
Health Limited |
3,567 |
3,758 |
(119) |
3.1% |
Evonetix
Limited |
2,999 |
3,383 |
- |
2.8% |
|
27,602 |
58,495 |
(181) |
48.2% |
|
|
|
|
|
Other
venture capital investments |
46,847 |
33,673 |
(2,430) |
27.8% |
|
|
|
|
|
|
74,449 |
92,168 |
(2,611) |
76.0% |
|
|
|
|
|
Cash
at bank and in hand/Money market funds |
|
29,104 |
|
24.0% |
|
|
|
|
|
Total
investments |
|
121,272 |
|
100.0% |
*Quoted on AIM All venture capital investments are unquoted
unless otherwise stated.
SUMMARY OF INVESTMENT MOVEMENTS
Investment additions |
|
|
|
Venture capital investments |
£’000 |
Morressier
GmbH |
3,162 |
Global
Satellite Vu Limited |
3,111 |
Melio
Healthcare Limited |
2,520 |
Binalyze
OU |
2,161 |
Oliva Health
Holdings Inc |
1,628 |
Allplants
Limited |
400 |
Apperio
Limited |
240 |
|
13,222 |
|
|
All venture capital investments are unquoted unless otherwise
stated.
UNAUDITED BALANCE SHEET as at
30 September 2023
|
30 Sept
2023 |
|
30 Sept
2022 |
|
31Mar2023 |
|
£’000 |
|
£’000 |
|
£’000 |
|
|
|
|
|
|
Fixed
assets |
|
|
|
|
|
Investments |
92,168 |
|
71,756 |
|
81,557 |
|
|
|
|
|
|
Current assets |
|
|
|
|
|
Debtors |
143 |
|
8 |
|
27 |
Cash at bank and in hand |
2,885 |
|
28,665 |
|
28,845 |
Money market fund investments |
26,219 |
|
- |
|
- |
|
29,247 |
|
28,673 |
|
28,872 |
|
|
|
|
|
|
Creditors: amounts falling due within one
year |
(101) |
|
(1,083) |
|
(117) |
|
|
|
|
|
|
Net current assets |
29,146 |
|
27,590 |
|
28,755 |
|
|
|
|
|
|
Net assets |
121,314 |
|
99,346 |
|
110,312 |
|
|
|
|
|
|
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
Called up Share capital |
12,146 |
|
9,406 |
|
10,347 |
Capital redemption reserve |
62 |
|
925 |
|
- |
Share premium account |
25,510 |
|
63,628 |
|
8,689 |
Special reserve |
63,602 |
|
2,285 |
|
65,178 |
Capital reserve - unrealised |
24,735 |
|
23,744 |
|
27,346 |
Capital reserve - realised |
(2,431) |
|
936 |
|
853 |
Revenue reserve |
(2,310) |
|
(1,578) |
|
(2,101) |
|
|
|
|
|
|
Equity Shareholders’ funds |
121,314 |
|
99,346 |
|
110,312 |
|
|
|
|
|
|
Basic and diluted Net Asset Value per Share |
49.9p |
|
52.8p |
|
53.3p |
UNAUDITED INCOME STATEMENT for
the six months ended 30 September 2023
|
Six months ended30 Sept 2023 |
Six months ended30 Sept 2022 |
Year ended31 Mar
2023 |
|
Revenue |
Capital |
Total |
Revenue |
Capital |
Total |
Total |
|
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
|
|
|
|
|
|
|
|
Income |
348 |
- |
348 |
- |
- |
- |
1 |
Gains on
investments |
|
|
|
|
|
|
|
Realised |
- |
- |
- |
- |
- |
- |
(1,036) |
Unrealised |
- |
(2,611) |
(2,611) |
- |
(6,922) |
(6,922) |
(3,890) |
|
348 |
(2,611) |
(2,263) |
- |
(6,922) |
(6,922) |
(4,925) |
|
|
|
|
|
|
|
|
Investment management fees |
(324) |
(973) |
(1,297) |
(289) |
(867) |
(1,156) |
(2,167) |
Performance incentive fees |
- |
- |
- |
- |
(621) |
(621) |
- |
Other expenses |
(233) |
- |
(233) |
(197) |
- |
(197) |
(468) |
|
|
|
|
|
|
|
|
(Loss) on
ordinary activities before
taxation |
(209) |
(3,584) |
(3,793) |
(486) |
(8,410) |
(8,896) |
(7,560) |
|
|
|
|
|
|
|
|
Tax on total
comprehensive income and ordinary activities |
- |
- |
- |
- |
- |
- |
- |
|
|
|
|
|
|
|
|
(Loss)
attributable to equity Shareholders |
(209) |
(3,584) |
(3,793) |
(486) |
(8,410) |
(8,896) |
(7,560) |
|
|
|
|
|
|
|
|
Basic and
diluted return per Share |
(0.1p) |
(1.6p) |
(1.7p) |
(0.3p) |
(4.4p) |
(4.7p) |
(4.0p) |
All Revenue and Capital items in the above
statement are derived from continuing operations. The total column
within the Income Statement represents the profit and loss account
of the Company.
UNAUDITED STATEMENT OF CHANGES IN
EQUITYfor the six months ended 30 September 2023
|
Called up Share capital |
Capital redemption
reserve |
Share premium |
Merger reserve |
Special reserve |
Capital
reserve-unrealised |
Capital
reserve-realised |
Revenue reserve |
Total |
|
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
£’000 |
At 1
April 2022 |
8,880 |
794 |
56,273 |
673 |
5,303 |
35,220 |
1,516 |
(1,092) |
107,567 |
Total
comprehensive income |
- |
- |
- |
- |
- |
(3,890) |
(2,661) |
(1,009) |
(7,560) |
Transfer between
reserves |
- |
- |
- |
(673) |
(3,239) |
(3,984) |
7,896 |
- |
- |
Cancellation of
Share Premium |
- |
- |
(63,628) |
- |
63,628 |
- |
- |
- |
- |
Cancellation of
Capital Redemption |
- |
(925) |
- |
- |
925 |
- |
- |
- |
- |
Transactions
with owners |
|
|
|
|
|
|
|
|
|
Issue of new
Shares |
1,598 |
- |
16,915 |
- |
- |
- |
- |
- |
18,513 |
Share issue
costs |
- |
- |
(871) |
- |
|
- |
- |
- |
(871) |
Purchase of own
Shares |
(131) |
131 |
- |
- |
(1,439) |
- |
- |
- |
(1,439) |
Dividends
paid |
- |
- |
- |
- |
- |
- |
(5,898) |
- |
(5,898) |
At 31
March 2023 |
10,347 |
- |
8,689 |
- |
65,178 |
27,346 |
853 |
(2,101) |
110,312 |
Total
comprehensive income |
- |
- |
- |
- |
- |
(2,611) |
(973) |
(209) |
(3,793) |
Transfer between
reserves |
- |
- |
- |
- |
(973) |
- |
973 |
- |
- |
Transactions
with owners |
|
|
|
|
|
|
|
|
|
Issue of new
Shares |
1,861 |
- |
17,838 |
- |
- |
- |
- |
- |
19,699 |
Share issue
costs |
- |
- |
(1,017) |
- |
- |
- |
- |
- |
(1,017) |
Purchase of own
Shares |
(62) |
62 |
- |
- |
(603) |
- |
- |
- |
(603) |
Dividends
paid |
- |
- |
- |
- |
- |
- |
(3,284) |
- |
(3,284) |
At 30
September 2023 |
12,146 |
62 |
25,510 |
- |
63,602 |
24,735 |
(2,431) |
(2,310) |
121,314 |
A transfer of £973,000 was made from the Special
Reserve to the Capital Reserve – realised in respect of capital
expenses for the period.
UNAUDITED STATEMENT OF CASH FLOWS
for the six months ended 30 September 2023
|
Six monthsended 30
Sept 2023 |
Six months ended 30
Sept 2022 |
Year ended31 Mar
2023 |
|
£’000 |
£’000 |
£’000 |
|
|
|
|
Cash
flow from operating activities |
|
|
|
Return on ordinary activities before taxation |
(3,793) |
(8,896) |
(7,560) |
Losses on investments |
2,611 |
6,922 |
4,926 |
(Increase)/decrease in debtors |
(113) |
14 |
(5) |
(Decrease)/increase in creditors |
(16) |
400 |
(179) |
|
|
|
|
Net cash
(outflow) generated from operating
activities |
(1,311) |
(1,560) |
(2,818) |
|
|
|
|
Cash flow from investing activities* |
|
|
|
Purchase of investments |
|
|
|
Venture capital investments |
(13,223) |
(8,209) |
(17,370) |
Money market funds |
(45,219) |
- |
- |
Sale of investments |
|
|
|
Venture capital investments |
- |
6,339 |
7,695 |
Money market funds |
19,000 |
- |
- |
|
|
|
|
Net cash
outflow from investing activities |
(39,442) |
(1,870) |
(9,675) |
|
|
|
|
Cash flows from financing activities |
|
|
|
Proceeds from Share issue |
19,699 |
8,424 |
(5,898) |
Share issue costs |
(1,019) |
(414) |
18,513 |
Purchase of own Shares |
(603) |
(1,112) |
(873) |
Equity dividends paid |
(3,284) |
(5,898) |
(1,499) |
|
|
|
|
Net cash
inflow from financing activities |
14,793 |
1,000 |
10,243 |
|
|
|
|
Net (decrease) in cash |
(25,960) |
(2,430) |
(2,520) |
|
|
|
|
Net movement in cash |
|
|
|
Beginning of period |
28,845 |
31,095 |
31,095 |
Net cash (outflow) |
(25,960) |
(2,430) |
(2,520) |
End of period |
2,885 |
28,665 |
28,845 |
NOTES TO THE UNAUDITED FINANCIAL
STATEMENTSfor the six months ended 30 September
20231. The unaudited Half-Yearly Report
covers the six months to 30 September 2023 and has been prepared in
accordance with the accounting policies set out in the statutory
accounts for the period ended 31 March 2023, which were prepared in
accordance with the Financial Reporting Standard 102 (“FRS 102”)
and the Statement of Recommended Practice “Financial Statements of
Investment Trust Companies” issued in July 2022 (“SORP”).
2. The Company has
only one class of business and derives its income from investments
made in shares, securities and bank deposits.
3. The comparative
figures are in respect of the six months ended 30 September 2022
and the year ended 31 March 2023, respectively.
4. Basic and
diluted return per Share
|
Six months ended 30
Sept 2023 |
|
Six months ended 30
Sept 2022 |
|
Year ended 31
Mar 2023 |
Return per Share based on: |
|
|
|
|
|
Net revenue (loss) (£’000) |
(209) |
|
(486) |
|
(1,009) |
|
|
|
|
|
|
Capital return per Share based on: |
|
|
|
|
|
Net capital (loss) (£’000) |
(3,584) |
|
(8,410) |
|
(6,551) |
|
|
|
|
|
|
Weighted average number of Shares |
224,828,251 |
|
189,766,121 |
|
190,419,643 |
5. Dividends
|
|
30 September 2023 |
|
31 March 2023 |
|
Per Share |
Revenue |
Capital |
Total |
|
Total |
|
Pence |
£’000 |
£’000 |
£’000 |
|
£’000 |
Forthcoming dividends |
|
|
|
|
|
|
2024 Interim (5 April 2024) |
1.0p |
- |
2,429 |
2,429 |
|
- |
|
|
- |
2,429 |
2,429 |
|
- |
Paid in the period |
|
|
|
|
|
|
2023 Final |
0.5p |
- |
1,214 |
1,214 |
|
- |
2023 Interim |
1.0p |
- |
2,070 |
2,070 |
|
- |
2022 Final |
3.1p |
- |
- |
- |
|
5,898 |
|
|
- |
3,284 |
3,284 |
|
5,898 |
6. Basic and
diluted Net Asset Value per Share
|
30 Sept 2023 |
|
30 Sept 2022 |
|
31 Mar 2023 |
Net asset value per Share based on: |
|
|
|
|
|
Net assets (£’000) |
121,314 |
|
99,346 |
|
110,312 |
|
|
|
|
|
|
Number of Shares in issue at period end |
242,913,196 |
|
188,123,911 |
|
206,931,912 |
|
|
|
|
|
|
Net Asset Value per Share |
49.9p |
|
52.8p |
|
53.3p |
7. Called up
Share capital
|
30 Sept 2023 |
|
30 Sept 2022 |
|
31 Mar 2023 |
Ordinary Shares of 5p each |
|
|
|
|
|
Number of Shares in issue at period end |
242,913,196 |
|
188,123,911 |
|
206,931,912 |
|
|
|
|
|
|
Nominal value (£’000) |
12,146 |
|
9,406 |
|
10,347 |
During the period, the Company allotted
36,846,664 Ordinary Shares of 5p each (“Shares”) under an Offer for
Subscription that launched in October 2022, at an average price of
52.96p per Share. Gross proceeds received thereon were £19.5
million, with issue costs in respect of the Offer amounting to £1.0
million.
During the period the Company allotted 367,620
Ordinary Shares of 5p each (“Shares”) under a Dividend Reinvestment
Scheme, at an average price of 50.29p per Share. Gross proceeds
received thereon were
£185,000.
During the period, the Company purchased Shares
for cancellation for an aggregate consideration of £603,000, at an
average price of 48.91p per Share (approximately equal to a 5.0%
discount to the most recently published NAV at the time of
purchase) and representing 0.6% of the share capital in issue as at
1 April 2023.
8. ReservesThe special
reserve is available to the Company to enable the purchase of its
own shares in the market without affecting its ability to pay
dividends and allows the Company to write back realised capital
losses arising on disposals and impairments.
Distributable reserves are calculated as
follows:
|
30 Sept2023 |
|
30 Sept2022 |
|
31 Mar2023 |
|
£’000 |
|
£’000 |
|
£’000 |
Special reserve |
63,602 |
|
2,285 |
|
65,178 |
Capital reserve - realised |
(2,431) |
|
936 |
|
853 |
Revenue reserve |
(2,310) |
|
(1,578) |
|
(2,101) |
Unrealised losses - net of unquoted gains |
(6,149) |
|
(1,057) |
|
(1,579) |
|
52,712 |
|
586 |
|
62,351 |
During the year ended 31 March 2023, the
balances on the Share Premium account and the capital redemption
reserve were cancelled and added to the special reserve,
contributing an additional £64.5 million to distributable reserves.
The VCT regulations place some restrictions on the use of these
reserves during the first three to four years after the funds on
which they arose were raised. Currently, £54.9 million of the
special reserve is restricted by these regulations.
9. InvestmentsThe fair
value of investments is determined using the detailed accounting
policy as set out in Note 1 of the Annual Report.
The Company has categorised its financial
instruments using the fair value hierarchy as follows:
Level
1 Reflects financial
instruments quoted in an active market (fixed interest investments,
and investments in shares quoted on either the Main or AIM
Markets);Level
2 Reflects financial
instruments that have prices that are observable either directly or
indirectly; andLevel
3 Reflects financial
instruments that use valuation techniques that are not based on
observable market data (unquoted equity investments and loan note
investments).
|
|
|
|
30 Sept 2023 |
|
Level 1 |
Level 2 |
Level 3 |
Total |
|
£’000 |
£’000 |
£’000 |
£’000 |
|
|
|
|
|
AIM quoted
shares |
4,135 |
356 |
- |
4,491 |
Loan notes |
- |
- |
508 |
508 |
Unquoted
shares |
- |
- |
87,169 |
87,169 |
|
4,135 |
356 |
87,677 |
92,168 |
|
|
|
|
31 Mar 2023 |
|
Level 1 |
Level 2 |
Level 3 |
Total |
|
£’000 |
£’000 |
£’000 |
£’000 |
|
|
|
|
|
AIM quoted
shares |
5,661 |
600 |
- |
6,261 |
Loan notes |
- |
- |
508 |
508 |
Unquoted
shares |
- |
- |
74,788 |
74,788 |
|
5,661 |
600 |
75,296 |
81,557 |
10. Risks
and uncertaintiesUnder the Disclosure and Transparency
Directive, the Board is required in the Company’s half-yearly
results to report on principal risks and uncertainties facing the
Company over the remainder of the financial year.
The Board has concluded that the key risks
facing the Company over the remainder of the financial period are
as follows:
- investment risk associated with
investing in small and immature businesses;
- liquidity risk arising from
investing mainly in unquoted businesses; and
- failure to maintain approval as a
VCT.
In all cases the Board is satisfied with the
Company’s approach to these risks. As a VCT, the Company is forced
to have significant exposure to relatively immature businesses.
This risk is mitigated to some extent by holding a well-diversified
portfolio.
With a reasonably illiquid venture capital
investment portfolio, the Board ensures that it maintains an
appropriate proportion of its assets in cash and liquid
instruments.
The Company’s compliance with the VCT
regulations is continually monitored by the Administration Manager,
who regularly reports to the Board on the current position. The
Company also retains Philip Hare and Associates LLP to provide
regular reviews and advice in this area. The Board considers that
this approach reduces the risk of a breach of the VCT regulations
to a minimal level.
The Company has considerable financial resources
at the period end and holds a diversified portfolio of investments.
As a result, the Directors believe that the Company is well placed
to manage its business risks successfully despite the current
uncertain economic outlook.
The Directors have concluded that the Company
has adequate resources to continue in operational existence for the
foreseeable future. Thus, they continue to adopt the going concern
basis of accounting in preparing the financial statements.
11. The Directors
confirm that, to the best of their knowledge, the half-yearly
financial statements have been prepared in accordance with the
“Statement: Half-Yearly Financial Reports” issued by the UK
Accounting Standards Board as well as in accordance with FRS 104
Interim Financial Reporting and the half-yearly financial report
includes a fair review of the information required by:
(a) DTR 4.2.7R of the Disclosure and
Transparency Rules, being an indication of important events that
have occurred during the first six months of the current financial
year and their impact on the condensed set of financial statements,
and a description of the principal risks and uncertainties for the
remaining six months of the year; and
(b) DTR 4.2.8R of the Disclosure and
Transparency Rules, being related party transactions that have
taken place in the first six months of the current financial year
and that have materially affected the financial position or
performance of the entity during that period, and any changes in
the related party transactions described in the last Annual Report
that could do so.
12. The unaudited
financial statements set out herein do not constitute statutory
accounts within the meaning of Section 434 of the Companies Act
2006 and have not been delivered to the Registrar of Companies. The
figures for the period ended 31 March 2023 have been extracted from
the financial statements for that period, which have been delivered
to the Registrar of Companies; the Auditor’s report on those
financial statements was unqualified.
13. Copies of the
unaudited Half-Yearly Report will be sent to Shareholders shortly.
Further copies can be obtained from the Company’s registered office
or downloaded from
investors.moltenventures.com/investor-relations/vct .
Molten Ventures Vct (LSE:MVCT)
Historical Stock Chart
From Dec 2024 to Jan 2025
Molten Ventures Vct (LSE:MVCT)
Historical Stock Chart
From Jan 2024 to Jan 2025